z-logo
open-access-imgOpen Access
Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study)
Author(s) -
Michael Feher,
William Hinton,
Anna Forbes,
Neil Munro,
Mark Joy,
David C. Wheeler,
Simon de Lusignan
Publication year - 2022
Publication title -
jmir research protocols
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.378
H-Index - 9
ISSN - 1929-0748
DOI - 10.2196/34206
Subject(s) - medicine , type 2 diabetes , glycemic , diabetes mellitus , glucagon like peptide 1 receptor , diabetes management , endocrinology , agonist , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom